- A new drug against Alzheimer's? Pros and cons aducanumab and beta amyloid pathway2021 | Second Faculty of Medicine
- Cerebrospinal fluid ratio of phosphorylated tau protein and beta amyloid predicts amyloid PET positivity2020 | Second Faculty of Medicine
- Assessment of total tau protein, phospho-tau and beta amyloid in cerebrospinal fluid: the first experience of our laboratory2004 | Second Faculty of Medicine
- The liquor tau protein and beta amylold in Alzheimer's disease2007 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Total and Phosphorylated Tau-protein and Beta-Amyloid 42 in Cerebrospinal Fluid in Dementias and Multiple Sclerosis2008 | Faculty of Medicine in Hradec Králové
- Total and Phosphorylated Tau-protein and Beta-Amyloid 42 in Cerebrospinal Fluid in Dementias and Multiple Sclerosis2008 | First Faculty of Medicine
- Tau protein, phospohorylated tau protein, and beta-amyloid 42 levels in patients with neurodegenerative diseases complicated by cognitive deficits +12009 | Faculty of Medicine in Hradec Králové
- Beta amyloid and tau protein in early differential diagnosis of dementiaPublication without faculty affiliation
- Tau protein and beta amyloid 42 in cerebrospinal fluid neurodegenerative diseasesPublication without faculty affiliation
- Borderline concentrations of a cerebrospinal fluid triplet of tau proteins and beta-amyloid 42 in the diagnosis of Alzheimer's disease and other neurodegenerative dementias2022 | First Faculty of Medicine, Third Faculty of Medicine
- Cerebrospinal Fluid Triplet in the Diagnosis of Alzheimer-Fischer disease2012 | Third Faculty of Medicine
- Tau protein and beta amyloid 42 in CSF of the patients with Alzheimer's disease and by other neurological disorderPublication without faculty affiliation
- Abnormalities of tau-protein and beta-amyloid in brain ventricle cerebrospinal fluid2009 | First Faculty of Medicine
- The Hypotheses of causes of Alzheimer's disease2016 | First Faculty of Medicine
- Tau protein, phospohorylated tau protein, and beta-amyloid 42 levels in patients with neurodegenerative diseases complicated by cognitive deficits2009 | First Faculty of Medicine
- Alzheimer's disease in a color of methylene blue2014 | Publication without faculty affiliation
- A review of known fluid biomarkers of neurodegeneration in Alzheimer's disease and contexts of use2019 | First Faculty of Medicine
- Pharmacotherapy of dementias2008 | First Faculty of Medicine
- Monodisperse Carboxyl-Functionalized Poly(Ethylene Glycol)-Coated Magnetic Poly(Glycidyl Methacrylate) Microspheres: Application to the Immunocapture of beta-Amyloid Peptides2014 | First Faculty of Medicine
- Intended pharmacotherapeutical approaches of Alzheimer's disease therapy2012 | Faculty of Pharmacy in Hradec Králové
- Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of beta-amyloid pathology2019 | First Faculty of Medicine
- Pharmacotherapy of dementia - advances in treatment and current recommendations2013 | Faculty of Medicine in Hradec Králové
- Abnormalities of tau-protein and beta-amyloid in brain ventricle cerebrospinal fluid2009 | Faculty of Medicine in Hradec Králové
- Advances in diagnosis of Alzheimer's disease2007 | Third Faculty of Medicine
- Tau protein, phosphorylated tau protein, and beta-amyloid 42 levels in patients with neurodegenerative diseases complicated by cognitive deficits A non-randomized, concurrent, case-control investigation2009 | Second Faculty of Medicine
- Physiological and pathological functions of beta-amyloid in the brain and alzheimer's disease: A review2020 | First Faculty of Medicine
- Specific spatial learning deficits become severe with age in beta-amyloid precursor protein transgenic mice that harbor diffuse beta-amyloid deposits but do not form plaques2001 | First Faculty of Medicine
- PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of beta-Amyloid Plaques2013 | Faculty of Science
- Tau protein and beta amyloid in cerebrospinal fluid in patients with multiple sclerosisPublication without faculty affiliation
